Please login to the form below
15
Revenue 2017Novo Nordisk
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.
Lilly’s Trulicity scores CV reduction indication in the US
The new MACE approval could help Lilly in its fight for market share with other GLP-1 agonists, including Novo Nordisk’s once-weekly drug Ozempic (semaglutide). ... Novo also has Rybelsus – oral semaglutide – in its arsenal, and analysts at Pareto
Novo Nordisk awakens its ‘Sleeping Beauty’
Novo Nordisk’s Biopharm is showing solid growth after a stuttering start, and its new leader believes a ‘sleeping beauty’ has been awoken. ... The small revolution we are also running in Novo Nordisk is to realise that we have many platforms at our
New drugs drive Novo Nordisk despite insulin price pressures
Novo Nordisk has revealed its fourth quarter report, posting a surprise increase in sales for the quarter but forecasted pricing pressure on its insulin products could hurt overall growth this year. . ... Operations and Region Europe,” said Novo’s
Givlaari, Rybelsus lead crowded CHMP recommendations
Joining Givlaari with a positive recommendation was Rybelsus (semaglutide), Novo Nordisk’s once-daily oral formulation of its injectable GLP-1 agonist semaglutide. ... In Novo’s Pioneer programme of the drug, people treated with Rybelsus achieved
Havas Lynx Group and VCCP Health win big at PM Society Awards
Other pharma Gold winners included ALK, Heart UK, Immunocore, Janssen, Mundipharma, Novo Nordisk and Santen. ... Target Award for Advertisement Campaign: Havas Lynx Group for Novo Nordisk.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Director, Healthcare Communications
-
Salary TBC
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Senior External Communications Lead
-
£Competitive Salary
-
Publications director
-
Competitive salary and bonus scheme
-
Account director
-
Competitive salary and bonus scheme
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Manager (PR)
-
Great Benefits
Subscribe to our email news alerts
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Merck KGaA divests allergy business to Dermapharm
- FDA accepts review to broaden GSK’s Zejula label
- Genital herpes vaccine candidate heads for human studies
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal
- Boehringer links up with Trutino for cancer R&D
- Acacia finally gets FDA okay for first product Barhemsys
- GSK seeks EU approval for Trelegy in adult asthma patients
- Raising awareness and encouraging support on Rare Disease Day 2020
- Case-study for thalassaemia: Dimitri Azzopardi
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- Case-study for thalassaemia: Dimitri Azzopardi
- An in-depth look at beta thalassaemia for Rare Disease Day...
- Delivering change through better rare disease communications
- OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes....
- Assessing the value of interim analyses in clinical trials
- Why its important and when its needed...
Quick links
Infographics
